Description
Generics: Mebhydrolin Napadisylate
Dosage Form: Tablet.
Indications:
- Allergic disease or symptoms such as urticaria
- Pruritus of various origin
- Eczema
- Itching
- Drug rash
- Insect bites
- Allergic conjunctivitis
- Dermatitis of nutritional origin
- Hay fever,
- Vasomotor rhinitis
- Allergic asthma.
Pharmacology:
Mebhydroline reduces or eliminates the main effects of histamine in the body by blocking histamine receptors.
Dosage guidelines:
Once daily. Advised by doctor.
- Adults and children over 10 years: 2-6 tablets daily
Children- - 5-10 years: 2-4 tablets daily
- 2-5 years: 1-3 tablets daily
- Up to 2 years: 1-2 tablets daily
- Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.
Route of administration: Orally.
Interaction:
The effects of atropine and tricyclic anti-depressants may be enhanced by Mebhydrolin. It may mask the warning symptoms of damage caused by ototoxic drugs.
Contraindications:
- Hypersensitivity to any of the ingredients of Mebhydrolin tablet or to mebhydrolin
- Prostatic hypertrophy, narrow-angle glaucoma.
- First trimester of pregnancy.
Side Effects:
Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.
Pregnancy & Lactation:
Safety in pregnancy and lactation has not been established.
Precautions & Warnings:
The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.
Safety in pregnancy and lactation has not been established.
Therapeutic Class:
Sedating Anti-histamine
Storage Conditions:
Store in a cool & dry place, protected from light. Keep all medicines out of reach of children.
Manufactured by:Â Â Beximco Pharmaceuticals Ltd.
